KB Financial Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$54K Buy
483
+89
+23% +$11.3K 0.02% 244
2023
Q2
$57K Buy
394
+14
+4% +$1.9K 0.02% 252
2023
Q1
$49K Hold
380
0.01% 263
2022
Q4
$48K Buy
380
+371
+4,122% +$43.1K 0.02% 261
2022
Q3
$1K Hold
9
﹤0.01% 580
2022
Q2
$1K Hold
9
﹤0.01% 575
2022
Q1
$1K Hold
9
﹤0.01% 600
2021
Q4
$1K Buy
+9
New +$1.18K ﹤0.01% 650
2021
Q3
Sell
-300
Closed -$47K 577
2021
Q2
$47K Sell
300
-35
-10% -$5.67K 0.02% 267
2021
Q1
$52K Buy
+335
New +$51.9K 0.02% 260

Other funds holding ZBH

KB Financial Partners's ZBH Position: Q3 2023 in Review

KB Financial Partners increased its Zimmer Biomet (ZBH) stake by 23% in Q3 2023, buying an estimated $11.3K and bringing the position to 483 shares worth $54K. The position accounts for 0.02% of the portfolio, ranked #244.

KB Financial Partners first reported a position in ZBH in Q1 2021 and has held it in 10 quarters since. The position peaked at $57K in Q2 2023. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

  • KB Financial Partners held 483 shares of Zimmer Biomet worth $54K as of Q3 2023.
  • KB Financial Partners bought 89 Zimmer Biomet shares in Q3 2023, an estimated $11.3K.
  • Zimmer Biomet made up 0.02% of KB Financial Partners's portfolio in Q3 2023, its #244 holding.
  • KB Financial Partners first reported a position in Zimmer Biomet in Q1 2021 and has held it in 10 quarters since.
  • KB Financial Partners's Zimmer Biomet position peaked at $57K in Q2 2023.
  • 1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.